Amazon Takes One Giant Step to Dominate the Healthcare Sector
We looked at One Medical's balance sheet to see if it could give us a clue as to what Amazon's vision for the company is. 
avatar
Precious Njoku is a Financial Writer with extensive knowledge about the stock market.
2022-07-24 11:00

Amazon (NASDAQ: AMZN), the global leader in online retailing and cloud solutions, is setting its sites on virtual care. According to documents reaching us, Amazon wants to add bricks-and-mortar doctor's offices to its list of clients and make them virtual. But this promises to be a long journey for the online retailer.Amazon Takes One Giant Step to Dominate the Healthcare Sector
In 2019, Amazon hinted that it was interested in the U.S. healthcare sector. First, it pioneered virtual care visits for its employees. Then it created the Amazon Care Brand to offer those services to other employers of labor. That was after it bought PillPack in 2018. PillPack is an online pharmacy central to Amazon’s goal of targeting U.S. healthcare. After acquiring PillPack and creating Amazon Care Brand, Amazon began a prescription delivery and price comparison site.

The online retailer announced recently that it had acquired One Medical (NASDAQ: ONEM) in a $3.49 billion deal. Although the shares of One Medical are trading at $17.12, Amazon agreed to buy them at a premium of $18. That underpins Amazon’s focus. Considering One Medical’s debt, the deal would be worth $3.9 billion, indicating Amazon’s desperation to have a significant virtual care provider among its subsidiaries.

We looked at One Medical's balance sheet to see if it could give us a clue as to what Amazon's vision for the company is.

One Medical Is A Sell In Our List
One Medical (NASDAQ: ONEM) is among the virtual healthcare providers that made profits during the pandemic. Some of the services it provides include immunization, lab, women's, and behavioral health services. It also has LGBTQ+ care and sports medicine services with a target market worth $300 billion. The company has captured 3% of that opportunity. The company keeps emphasizing that it has a lot of room for growth. Despite this, its stock value has been falling since June 2021.

Last year, it acquired Iora Health, a Boston company with about 38,000 seniors among its patients. But investors were not impressed with the acquisition. The truth is that One Medical was not doing enough to expand into its target market.

On the bright side, One Medical has been growing as its target market has also been growing. But its stock is losing value because the costs associated with its growth are very high. Its net loss for Q1 2022 was $90.9 million, on revenue of $254.1 million. Amazon is buying all of that debt in its recent acquisition.

For the past year, its stock has lost 38% of its value, although it jumped 65% this week on the news of Amazon’s acquisition. After analyzing the stock value, we believe that Amazon is buying it for reasons beyond One Medical’s balance sheet.

Why Amazon Is Buying One Medical
You must note that Amazon (NASDAQ: AMZN) is still a tiny player in the U.S. healthcare sector. If it needs to grab a considerable share of this sector, it needs a company like One Medical (NASDAQ: ONEM). This acquisition would accelerate Amazon’s ambitions. In a recent statement, Neil Lindsay, Vice President of Amazon Health Services, said that the company is on the lookout for services that need reinvention and believes that healthcare is on that list. Therefore, Amazon is prioritizing healthcare.

Despite that, Amazon does not have a big idea yet. We are looking for something big like the one Amazon implemented for bricks-and-mortar stores when it automated the role of cashiers. If Amazon can improve healthcare and speed it up, it needs the services that One Medical offers.

It is not surprising, then, that Amazon is acquiring a loss-making company. However, Amazon is looking beyond that and at the company's potential. It has lots of big-name clients, like Airbnb and Alphabet Inc. One Medical also has lots of members on its membership list, and Amazon will be looking to leverage that. Among those members are Google's employees since Google uses its services to benefit its employees.




Disclaimer: I have no positions in any of the stocks mentioned. I wrote this article myself, and it expresses my own opinions. I have no business relationship with any company whose stock is mentioned in this article. All information should be independently verified and should not be relied upon for purposes of transacting securities or other investments. See terms for more info.

Rate this article

positive
negative
Published On
2022-07-24 11:00

avatar
About the Author
Precious Njoku is a Financial Writer with extensive knowledge about the stock market.

Analyst Ratings
Target Price$139.89
# of Analysts47
Last updated2022-12-19

buy-coffee
You've read 1 article in the last year
..thank you for supporting us and for visiting our site. Unlike many other sites, The Dog of Wall Street is available for everyone to read. Our focus is to provide great content for free. Do you like what we are doing? Buy us a cup coffee. It is the fuel that keeps us going..

Is Tesla Back? Has TSLA Stock Finally Bottomed?
Tesla Stock Analysis: Robo Taxis to the Rescue?
By Mike Sakuraba | 2 weeks ago

2 Stocks to Buy During an April Pullback
Here are 2 stocks I’d buy during an April pullback.
By Mike Sakuraba | 2 weeks ago

TSM Stock: Is This The True Winner of the AI Race?
TSM’s stock has gained nearly 40% this year which is about half of NVIDIA has returned.
By Mike Sakuraba | 2 weeks ago

Best Proxy for Bitcoin: Coinbase or IBIT
In this article, we’ll compare the iShares Bitcoin Trust to Coinbase to see which is the best proxy for Bitcoin on the stock market.
By Mike Sakuraba | 3 weeks ago

2 Under the Radar AI Stocks to Buy
If you’re tired of reading about NVIDIA, consider these two AI stocks to add while the chip market cools off.
By Mike Sakuraba | 3 weeks ago

3 Bold Predictions for the Second Quarter
So here’s what I’m expecting for the second quarter and I’ll throw in a couple of bold predictions as well!
By Mike Sakuraba | 3 weeks ago

2 Stocks Cathie Wood Keeps Buying That You Should Too
In the world of retail investing, Cathie Wood and her Ark Invest fund are extremely polarizing.
By Mike Sakuraba | 1 month ago

2 Under the Radar Stocks to Buy Before Others
One of the keys to investing has always been to identify weaknesses in stocks before others. Buy it when everyone hates it and when everyone loves it you’ll reap the rewards. Sounds easy enough right?
By Mike Sakuraba | 1 month ago